Page last updated: 2024-08-16

ribavirin and Hyperglycemia

ribavirin has been researched along with Hyperglycemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blum, JS; Daniel, AL; Houlihan, JL; Walsh, JP	1
Adorni, F; Antinori, S; Caramma, I; Cesari, M; Galli, M; Milazzo, L	1
Bani-Sadr, F; Bentata, M; Cacoub, P; Carrat, F; Goujard, C; Hor, R; Lunel-Fabiani, F; Morand, P; Perronne, C; Pialoux, G; Piroth, L; Pol, S; Rosenthal, E; Salmon-Ceron, D	1

Reviews

1 review(s) available for ribavirin and Hyperglycemia

Article	Year
Type B insulin resistance developing during interferon-alpha therapy. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2009, Volume: 15, Issue:2 Topics: Autoantibodies; Hepatitis C; Humans; Hyperglycemia; Immunoprecipitation; Insulin Resistance; Interferon-alpha; Male; Middle Aged; Receptor, Insulin; Ribavirin	2009

Article

Year

Type B insulin resistance developing during interferon-alpha therapy.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2009, Volume: 15, Issue:2

Topics: Autoantibodies; Hepatitis C; Humans; Hyperglycemia; Immunoprecipitation; Insulin Resistance; Interferon-alpha; Male; Middle Aged; Receptor, Insulin; Ribavirin

2009

Other Studies

2 other study(ies) available for ribavirin and Hyperglycemia

Article	Year
Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients. HIV medicine, 2009, Volume: 10, Issue:9 Topics: Adult; Antiviral Agents; Blood Glucose; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Hypercholesterolemia; Hyperglycemia; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Lipodystrophy; Lipoproteins, LDL; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Triglycerides; Viral Load	2009
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. Journal of acquired immune deficiency syndromes (1999), 2005, Sep-01, Volume: 40, Issue:1 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Hyperglycemia; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mitochondria; Multivariate Analysis; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome	2005

Article

Year

Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients.

HIV medicine, 2009, Volume: 10, Issue:9

Topics: Adult; Antiviral Agents; Blood Glucose; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Hypercholesterolemia; Hyperglycemia; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Lipodystrophy; Lipoproteins, LDL; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Triglycerides; Viral Load

2009

Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.

Journal of acquired immune deficiency syndromes (1999), 2005, Sep-01, Volume: 40, Issue:1

Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Hyperglycemia; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mitochondria; Multivariate Analysis; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome

2005